首页 | 本学科首页   官方微博 | 高级检索  
     


Terbinafine resistance in dermatophytes: Time to revisit alternate antifungal therapy
Affiliation:1. Global Action Fund for Fungal Infections (GAFFI), Geneva, Switzerland;2. Univ Rennes, CHU, Inserm, Irset (Institut de recherche en santé, environnement et travail) – UMR_S 1085, F-35000 Rennes, France;3. Société Française de Mycologie Médicale (SFMM), Paris, France;4. Manchester Fungal Infection Group, The University of Manchester, Manchester, United Kingdom
Abstract:
Resistant superficial dermatophytic infections of the skin and its appendages have emerged as a major health problem in India. Mutations in Squalene epoxidase gene have led to increasing incidence of resistance to terbinafine in dermatophytic isolates. We examined six patients with recalcitrant dermatophytosis attending Dermatology OPD at a tertiary care hospital and demonstrated terbinafine resistance by molecular method. Immediate hyperitivity (IH) reaction to Trichophytin antigen was highlighted in these patients. The patients were treated with alternate antifungals after demonstration of resistance to terbinafine based on the antifungal susceptibility testing (AFST). On follow up the patients responded well to the substitute but the duration of therapy had to be prolonged beyond six weeks.
Keywords:Tinea corporis/cruris  Terbinafine  SQLE mutation
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号